Free Trial

Labcorp (LH) Stock Forecast & Price Target

Labcorp logo
$279.68 +1.80 (+0.65%)
As of 12:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Labcorp - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
4
Buy
10

Based on 14 Wall Street analysts who have issued ratings for Labcorp in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 4 have given a hold rating, and 10 have given a buy rating for LH.

Consensus Price Target

$292.00
4.41% Upside
According to the 14 analysts' twelve-month price targets for Labcorp, the average price target is $292.00. The highest price target for LH is $311.00, while the lowest price target for LH is $260.00. The average price target represents a forecasted upside of 4.41% from the current price of $279.68.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for LH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Labcorp and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LH Analyst Ratings Over Time

TypeCurrent Forecast
10/13/24 to 10/13/25
1 Month Ago
9/13/24 to 9/13/25
3 Months Ago
7/15/24 to 7/15/25
1 Year Ago
10/14/23 to 10/13/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
9 Buy rating(s)
9 Buy rating(s)
10 Buy rating(s)
Hold
4 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$292.00$290.33$276.38$253.00
Forecasted Upside4.41% Upside4.41% Upside12.47% Upside16.92% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

LH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Labcorp Stock vs. The Competition

TypeLabcorpMedical CompaniesS&P 500
Consensus Rating Score
2.71
2.33
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside5.05% Upside1,034.85% Upside177.78% Upside
News Sentiment Rating
Positive News

See Recent LH News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/8/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingBuy (B-)
10/3/2025Evercore ISI
3 of 5 stars
Boost TargetOutperform$300.00 ➝ $305.00+9.31%
10/2/2025Barclays
3 of 5 stars
Jack Meehan
Not Rated
Boost TargetEqual Weight$275.00 ➝ $290.00+3.81%
8/25/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Target$311.00+12.07%
7/25/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$282.00 ➝ $305.00+15.23%
7/25/2025Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$290.00 ➝ $310.00+17.12%
7/25/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$283.00 ➝ $306.00+14.43%
7/10/2025Hsbc Global Res
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
7/10/2025HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyHold$260.00+0.21%
5/6/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$260.00 ➝ $280.00+13.84%
4/2/2025Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$276.00+18.64%
3/4/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutralBuy$250.00 ➝ $300.00+18.11%
2/6/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$275.00 ➝ $290.00+17.25%
12/13/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$262.00 ➝ $271.00+16.67%
8/2/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetHold$220.00 ➝ $230.00-2.35%
5/30/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetOverweight$261.00 ➝ $243.00+25.49%
3/25/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeHoldBuy$250.00+17.23%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageOutperform$260.00+18.63%
10/31/2023Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetBuy$257.00 ➝ $230.00+16.07%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:24 PM ET.


Should I Buy Labcorp Stock? LH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, October 11, 2025. Please send any questions or comments about these Labcorp pros and cons to contact@marketbeat.com.

Labcorp
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

  • The current stock price is around $262.39, reflecting a strong performance in the market.
  • Recent data shows a 26.58% increase in the company's performance over the past year, indicating robust growth potential.
  • Institutional ownership is high at approximately 96.69%, suggesting confidence from large investors in the company's future prospects.
  • The average daily trading volume is around 788,200 shares, which indicates good liquidity and investor interest.
  • Despite a slight increase in short interest, the short percentage of float remains relatively low at about 4.27%, which may indicate a stable outlook among investors.

Labcorp
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Laboratory Co. of America Holdings for these reasons:

  • There has been a recent increase in short interest, with shares shorted rising to 3.56 million, which may indicate growing skepticism about the company's future performance.
  • The days to cover has increased to 4.5, suggesting that it may take longer for short sellers to cover their positions, which could lead to volatility.
  • Although the company has shown growth, the month-to-month change in short interest was positive, indicating a potential shift in investor sentiment.
  • The float size is relatively large at approximately 83.39 million shares, which can sometimes lead to increased price volatility.
  • While institutional ownership is high, it also means that the stock may be more susceptible to large sell-offs by these investors, which could negatively impact the stock price.

LH Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Labcorp is $292.00, with a high forecast of $311.00 and a low forecast of $260.00.

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Labcorp in the last twelve months. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" LH shares.

According to analysts, Labcorp's stock has a predicted upside of 4.41% based on their 12-month stock forecasts.

Labcorp has been rated by research analysts at Barclays, Evercore ISI, Morgan Stanley, Robert W. Baird, Truist Financial, UBS Group, and Weiss Ratings in the past 90 days.

Analysts like Labcorp more than other "medical" companies. The consensus rating for Labcorp is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how LH compares to other companies.


This page (NYSE:LH) was last updated on 10/13/2025 by MarketBeat.com Staff
From Our Partners